Episode 42: The Future of Chronic Disease Management with xbird

Why is chronic illness management lagging in innovation? How can doctors and patients be better equipped and more empowered to manage their health issues? And how has Covid impacted this market?

Chronic illness, especially Type 2 diabetes, is more complex than acute injuries when it comes to monitoring health and making adjustments over the long-term. It typically requires patients to catalogue all aspects of their life in disjointed methods in the hopes that their doctor will be able to understand the big picture and catch any issues as they arise. It’s for this reason that xbird came into being. A digital platform streamlines the process of monitoring, managing and notifying patients of their health—all in a user-friendly app. Join myself and Founder Sebastian Sujka as we explore the possibilities that xbird is creating in their industry, and what that means for the future of chronic illness management.


Clara Mouawad

Clara is the Content Specialist at BCC Research, where she spends her time writing blogs and white papers, designing graphics and thinking up ways BCC can take over the world...like with a podcast.

A world traveler (less so during COVID19, of course), marketing whiz and always thirsty for knowledge, Clara finds innovators in a variety of fields and asks the question that our listeners want to know: How will this industry, technology or company shape how we live and work in the future?

Episode Timeline

  • [00:00]Introducing the chronic disease management industry and bird
  • [01:38]Sebastian's sorry and what led him to create bird
  • [03:42]The current chronic disease management landscape
  • [06:10]xbird's mission
  • [10:44]xbird's AI-powered 3-step process to their technology
  • [15:26]xbird's SDK and what it allows them to do
  • [18:10]On the security and privacy of users
  • [21:34]Data privacy and regulations
  • [24:47]The impact of Covid-19 on the industry and bird
  • [27:51]The future of chronic disease management in 10-15 years.